- September 2017 Godbout J (Primary Investigator). Acute and Long-Term Benefits of Methylene Blue Intervention After TBI on Neuroinflammation, Glial Dysfunction, and Neuropsychiatric Complications. NIH R01, National Institute of Neurological Disorders and Stroke. Co-Investigator
- March 2016 Godbout J, Sheridan J, Eiferman D. “The Elimination of Microglia by a CSF-1R Antagonist to Prevent or Reverse TBI-induced Chronic Inflammation Associated with Microglia Priming and Reactivity.” Discovery Theme Chronic Brain Injury Pilot Program, The Ohio State University. Co-Investigator.
- Jul 2014 Eiferman D, Godbout J, "Attenuation of Neuroinflammation by Methylene Blue Intervention in a Mouse Model of Traumatic Brain Injury. American Surgical Association. Principal Investigator.
- Oct 2013 Godbout J, Eiferman D, "Methylene Blue Intervention to Attenuate Traumatic Brain Injury-Associated Microglial Priming and Reactivity" Ohio State University College of Medicine, Co-Investigator.